- Tags: IRIS Registry
Research
Real-world data finds anti-VEGF use may not disrupt IZERVAY dosing patterns
IRIS Registry study demonstrates similarities in safety and dosing intervals among patients undergoing concomitant anti-VEGF and IZERVAY therapy.
Research
How do postop corticosteroids compare to an intracanalicular dexamethasone insert?
Real-world registry data suggests similar safety outcomes, with the insert offering a drop-free alternative for postoperative care.
Research
Real-world TED data finds disease advances beyond acute phase
Real-world study demonstrates heterogeneous disease progression in TED, challenging the traditional self-limited paradigm.
Research
IRIS Registry data analysis predicts goniotomy success rates
Study identifies new factors that predict successful outcomes following goniotomy.
Research
IRIS Registry-based data predicts significant IOP response
IOP response after cataract surgery linked with certain traits, such as baseline IOP, age, and male sex.
Research
Verana Health launches real-world data TED module
Dataset includes over 250,000 de-identified patients from the AAO IRIS Registry to advance disease clinical research.
Research
IRIS Registry identifies key factors for post-cataract IOP spikes
IOP spikes occurred at a rate of 3.7% following standalone phacoemulsification.
Research
AAO and Research to Prevent Blindness announce award recipients for IRIS Registry Research
Four ophthalmologists will gain access to conduct population-based studies in ophthalmology and blindness prevention.
Research
Assessing the significance of the IRIS Registry wide-scale MIGS study
Verana Health Senior Medical Director Michael Mbagwu, MD, dives into implications from this research.
Research
Sight Sciences releases 12-month results from first MIGS analysis of AAO Registry real-world data
First large-scale comparative study assessed procedures in combination with cataract surgery.
Research